| 000 | 01841 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515062622.0 | ||
| 264 | 0 | _c20070627 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0393-6155 | ||
| 024 | 7 |
_a10.1177/172460080702200101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuo, L | |
| 245 | 0 | 0 |
_aIndividualized survival and treatment response predictions for breast cancers using phospho-EGFR, phospho-ER, phospho-HER2/neu, phospho-IGF-IR/In, phospho-MAPK, and phospho-p70S6K proteins. _h[electronic resource] |
| 260 |
_bThe International journal of biological markers _c |
||
| 300 |
_a1-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aArtificial Intelligence |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aErbB Receptors _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xanalysis |
| 650 | 0 | 4 |
_aPhosphoproteins _xanalysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
| 650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 70-kDa _xanalysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAbraham, J | |
| 700 | 1 | _aFlynn, D C | |
| 700 | 1 | _aCastranova, V | |
| 700 | 1 | _aShi, X | |
| 700 | 1 | _aQian, Y | |
| 773 | 0 |
_tThe International journal of biological markers _gvol. 22 _gno. 1 _gp. 1-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/172460080702200101 _zAvailable from publisher's website |
| 999 |
_c16947296 _d16947296 |
||